Correlation Between Acurx Pharmaceuticals and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Acurx Pharmaceuticals and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acurx Pharmaceuticals and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acurx Pharmaceuticals LLC and Eupraxia Pharmaceuticals, you can compare the effects of market volatilities on Acurx Pharmaceuticals and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acurx Pharmaceuticals with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acurx Pharmaceuticals and Eupraxia Pharmaceuticals.
Diversification Opportunities for Acurx Pharmaceuticals and Eupraxia Pharmaceuticals
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Acurx and Eupraxia is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Acurx Pharmaceuticals LLC and Eupraxia Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Acurx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acurx Pharmaceuticals LLC are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Acurx Pharmaceuticals i.e., Acurx Pharmaceuticals and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Acurx Pharmaceuticals and Eupraxia Pharmaceuticals
Given the investment horizon of 90 days Acurx Pharmaceuticals LLC is expected to generate 1.14 times more return on investment than Eupraxia Pharmaceuticals. However, Acurx Pharmaceuticals is 1.14 times more volatile than Eupraxia Pharmaceuticals. It trades about -0.07 of its potential returns per unit of risk. Eupraxia Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest 287.00 in Acurx Pharmaceuticals LLC on November 5, 2024 and sell it today you would lose (214.00) from holding Acurx Pharmaceuticals LLC or give up 74.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 32.93% |
Values | Daily Returns |
Acurx Pharmaceuticals LLC vs. Eupraxia Pharmaceuticals
Performance |
Timeline |
Acurx Pharmaceuticals LLC |
Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acurx Pharmaceuticals and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acurx Pharmaceuticals and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Acurx Pharmaceuticals and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acurx Pharmaceuticals position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Directory Find actively traded commodities issued by global exchanges |